Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial
Conditions: Hand, Foot and Mouth Disease; Herpangina Interventions: Biological: low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated; Biological: medium dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated; Biological: high dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated; Biological: Enterovirus type EV71 vaccine (Vero cell), Inactivated Sponsors: Sinovac Biotech Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Clinical Trials | Enterovirus | Hand, Foot and Mouth | Research | Vaccines